Preview Newsletter
XARELTO Media Monitoring – Week of 7-22-16
-
FDA Warns Of Severe Bleeding Risks Associated With Over-The-Counter Antacid Containing Aspirin
Jul 18, 2016 | Southern Med Law
By Editor
The U.S. Food and Drug Administration (FDA) is warning that over-the-counter aspirin-containing antacids may cause internal bleeding. The agency advises consumers to read safety labels of over-the-counter medications that treat upset stomach, sour stomach, acid indigestion or heart burn to see if they contain aspirin before taking them. Some OTC antacids containing aspirin, and that may pose a risk of severe internal bleeding may include Alka-Seltzer, Bromo Seltzer, And Other NSAIDS. The FDA first warned about bleeding risks with aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) in 2009. Since that time, the agency reviewed its Adverse Event Reporting System database and found eight new cases of serious bleeding caused by aspirin-containing antacid products. In some cases, blood transfusions were needed. -
Man files Xarelto Lawsuit after Wife dies from Gastrointestinal Bleeding
Jul 18, 2016 | Xareltolawsuit.com
By Miller Legal LLP
In a recent Xarelto wrongful death lawsuit, a man claims that his wife’s death from complications following internal bleeding may have been avoided had drug makers provided adequate warning of Xarelto bleeding risks and the lack of an antidote for Xarelto internal bleeding. -
Texas Woman Files Xarelto Lawsuit After Dangerous Bleeding
Jul 18, 2016 | Consumer Advocacy News
By Andrew Steinberg
A Texas woman joined the multidistrict litigation against Xarelto manufacturers, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) and Bayer AG, after suffering severe complications from taking the popular blood thinner. The woman alleges the drug’s manufacturers failed to warn the public of the serious bleeding risks associated with Xarelto. -
Studies could authenticate plaintiff claims in Xarelto Lawsuit
Jul 19, 2016 | Zhong Zhilihe
According to a new report from Product Layers, two new types of research have come forward which could prove to be crucial in the upcoming litigation against Xarelto. Currently facing the heat from more than 2800 lawsuits in a multidistrict litigation, Bayer and Johnson & Johnson – the manufacturers of Xarelto (rivaroxaban), would be cursing their luck after a single glance at the new pieces of evidence. -
Anticoagulant Xarelto Lawsuit Cases Keep Drawing Attention
Jul 20, 2016 | News Inferno
By Mara Lepmanis
Lawsuits seeking damages from the makers of Xarelto, Bayer AG and Janssen Pharmaceuticals (a subdivision of Johnson & Johnson), have surpassed 3,000 in number with many plaintiffs alleging they suffered similar harm resulting from taking the drug, reports the Digital Journal. -
Xarelto Lawsuit: Manufacturers Were Warned About Misleading Ads
Jul 19, 2016 | Top Class Actions
By Tamara Burns
A lawsuit has been filed against Janssen Pharmaceuticals and Bayer AG by a group of 10 people whose family members had allegedly died from Xarelto use. -
Hire a Xarelto Lawyer for Its Dangerous Side Effects
Jul 21, 2016 | Healthable
By Editorial
All the more usually known as Xarelto is essentially a FXa inhibitor that aides in the shirking of profound vein thrombosis that may bring about pneumonic embolism in individuals who are experiencing a hip or knee substitution surgery. Remember that your specialists will just recommend you to it if they judge that it will advantage you in one way or the other. He will likewise remember that there are a few symptoms that this medication causes, so theadvantage of this medication must be more noteworthy than the danger of reactions in your specific case. A great deal of times it does not have any serious symptoms. -
Know something about the Health Issues from Xarelto Lawsuit
| Medical Island
By Julius Rogers
In the legal and medication world, there is much going on today. All this is due to a drug that has caused more harm than it claims it can cure. There is a large volume of lawsuits filed by patients who used Xarelto. It is a medication used for blood thinning which was approved by the Food and Drug Association (FDA) in the year 2011. However, the drug turned out to be a disaster with exhilarating side effects to most people who consumed the drug. Regardless the fact that most drugs have side effects, Xarelto is exceptional after information emerged that it was approved carelessly without knowing its harm. The drug was made by Bayer and widely marketed and distributed by Janssen Pharmaceuticals in Japan a section of Johnson and Johnson. -
New Jersey Couple Alleges Xarelto Caused Stroke
Jul 21, 2016 | Top Class Actions
By Joanna Szabo
A New Jersey couple recently filed a Xarelto lawsuit against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, alleging that Xarelto caused stroke.
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
Plaintiff Attorney Press Releases
Plaintiff Attorney Blog Posts
Full Text of Stories Below
-
FDA Warns Of Severe Bleeding Risks Associated With Over-The-Counter Antacid Containing Aspirin
Jul 18, 2016 | Southern Med Law
By Editor
The U.S. Food and Drug Administration (FDA) is warning that over-the-counter aspirin-containing antacids may cause internal bleeding. The agency advises consumers to read safety labels of over-the-counter medications that treat upset stomach, sour stomach, acid indigestion or heart burn to see if they contain aspirin before taking them. Some OTC antacids containing aspirin, and that may pose a risk of severe internal bleeding may include Alka-Seltzer, Bromo Seltzer, And Other NSAIDS. The FDA first warned about bleeding risks with aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) in 2009. Since that time, the agency reviewed its Adverse Event Reporting System database and found eight new cases of serious bleeding caused by aspirin-containing antacid products. In some cases, blood transfusions were needed.
In its warning, the FDA cautioned that since it only reviewed cases from its own database, more OTC aspirin-related bleeding cases have probably occurred but have gone unreported. OTC Aspirin-containing antacid products are sold under different trade names such as Alka-Seltzer Original, Bromo Seltzer, Picot Plus Effervescent, Winco Foods Effervescent Antacid and Pain Relief, and Zee-Seltzer Antacid and Pain Reliever. In its safety warning issued in June, the FDA recommended consumers take over-the-counter products that relieve heartburn and stomach symptoms and do not contain aspirin.
[fda.gov/Drugs/DrugSafety/ucm504328.htm]“Consumers may not realize that the familiar antacid products they routinely use to treat stomach upsets or heart burn can cause side effects, and even more serious health conditions. People should be aware of the FDA’s findings” says Southern Med Law attorneys.
Southern Med Law is currently investigating antacid bleeding risk lawsuits after speaking with people who have had side-effects from over-the-counter antacids. The firm has also launched a webpage to keep consumers aware of any information or news on this and other dangerous drug lawsuits. If you or a loved one believe you have experienced internal bleeding as a result of regularly taking over-the-counter antacids that contain aspirin to remedy acid indigestion, heart burn or an upset stomach, contact Southern Med Law for a free antacid bleeding risk lawsuit consultation and get the help you deserve. You can speak with one of the firms attorney’s by calling 205-547-5525 or you can visit www.southernmedlaw.com and fill out the contact form on our website.
Aspirin is considered a nonsteroidal anti-inflammatory drug (NSAID) that consumers commonly use to treat headache, body aches and pains, and reduce fever. In addition to aspirin, other popular NSAIDs include ibuprofen (Advil, Motrin) and naproxen (Aleve). The eight antacid cases the FDA highlighted were among 41 total reports the agency received from 1969 to 2014. All of the patients were hospitalized in these reports. Most of the patients recovered. However, one death was reported but the case provided few details of the patient’s underlying medical conditions or the cause of death. [fda.gov/ForConsumers/ConsumerUpdates/ucm505110.htm, FDA, June 6, 2016]
The FDA says individuals at risk for internal bleeding:
• Are over 60
• Have a history of stomach ulcers or bleeding problems
• Take blood thinners
• Take a steroid medicine to reduce inflammation
• Take other medicines containing NSAIDs
• Drink three or more alcoholic drinks every day.These were underlying conditions reported in the eight cases of severe bleeding reported to the FDA since 2009.
In 2009, the FDA issued a safety alert that NSAIDs could cause bleeding in the stomach and gastrointestinal tract. Besides internal bleeding, the federal regulator also warned that NSAIDs have the potential to cause heart attacks and strokes. Due to the life-threatening injuries associated with NSAIDs, the FDA required NSAID manufacturers to carry a warning on their products’ safety labels about the bleeding and cardiovascular risks.
[fda.gov/ForConsumers/ConsumerUpdates/ucm453610.htm, FDA, July 9, 2015]About Southern Med Law And Filing An Antacid Bleeding Risk Lawsuit
Southern Med Law is a patient and consumer advocacy organization providing legal representation to the victims of negligent personal injuries, medical malpractice, dangerous drugs, faulty medical devices and defective products. Led by Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in all manner of product liability and personal injury claims. They’re not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.
https://www.southernmedlaw.com/fda-warns-counter-antacids-containing-aspirin-may-cause-severe-internal-bleeding/3376
-
Man files Xarelto Lawsuit after Wife dies from Gastrointestinal Bleeding
Jul 18, 2016 | Xareltolawsuit.com
By Miller Legal LLP
In a recent Xarelto wrongful death lawsuit, a man claims that his wife’s death from complications following internal bleeding may have been avoided had drug makers provided adequate warning of Xarelto bleeding risks and the lack of an antidote for Xarelto internal bleeding.
Robert Smith filed his Xarelto lawsuit on July 12 in the U.S. District Court for the Eastern District of Louisiana, where it will be centralized as part of a Xarelto multidistrict litigation (MDL) which already contains more than 5,000 other lawsuits against Janssen Pharmaceuticals and their parent company Johnson & Johnson as well as Bayer Healthcare and subsidiaries. Here, he claims that the death of his wife, Sylvia Ann Smith, was a result of Xarelto side effects of which the drug makers failed to provide adequate warning.
According to claims made in Mr. Smith’s lawsuit, Mrs. Smith began to use Xarelto in April 2014 and within three months she suffered severe gastrointestinal bleeding. Sylvia Ann Smith died as a result of complications caused by this alleged Xarelto internal bleeding in February 2015.
In his lawsuit, Smith echoes the statements of multiple other plaintiffs and medical experts who claim that the once-daily dosing which was one of the factors that made Xarelto more appealing to his wife and other patients is also one of the factors that makes Xarelto a dangerous drug. Xarelto (rivaroxaban) was embraced when it was introduced as a new-generation blood thinner in 2011. Part of the appeal of Xarelto was that it was touted to be a more convenient option than the previous go-to blood thinner Coumadin (warfarin) because patients only needed to take it once a day and because they would not be required to undergo routine blood monitoring as warfarin patients do. However, in light of a high number of adverse event reports based on claims of Xarelto internal bleeding, experts now believe that it would be safer for patients to take Xarelto twice a day to ensure more constant levels of the drug in their bodies, and that regular blood tests may help doctors make sure their blood is clotting sufficiently.
Smith states, “The use of Xarelto without appropriate blood monitoring, dose adjustment and twice a day dosing can cause major, life-threatening bleeding events. Physicians using Xarelto have been able to balance the dose so that the blood is thinned enough to reduce the risk of stroke, but not thinned so much as to increase the risk for a major bleeding event. The Defendants were aware of this risk and the need for blood monitoring but have failed to disclose this vital health information to patients, doctors and the FDA.”
Recently, the Institute for Safe Medication Practices (ISMP) revealed that Xarelto had caused more severe injuries than any other drug monitored in 2015, and that the many adverse event reports submitted regarding Xarelto injuries included at 1,100 reports of patient deaths from Xarelto side effects. In this QuarterWatch report, the advocacy group also criticized the aggressive direct-to-consumer marketing of Xarelto regarding the convenience of a once-daily dose and stated, “A major misstep in patient safety occurred with the approval of new generation anticoagulants marketed for ease of use rather than improved safety or efficacy.”
Mr. Smith’s lawsuit has been centralized before U.S. District Judge Eldon Fallon in Louisiana, and the first trials in this MDL are set to begin in February of next year. Even as progress continues in the Xarelto MDL, potential plaintiffs are investigating additional Xarelto lawsuits after suffering serious injuries or the loss of a loved one due to Xarelto side effects. To learn more about Xarelto lawsuits and whether you may be entitled to compensation for your suffering and damages, please contact us for a free consultation with an experienced lawyer.
http://www.xareltolawsuit.com/news/xarelto-lawsuit-wife-dies-gastrointestinal-bleeding/
-
Texas Woman Files Xarelto Lawsuit After Dangerous Bleeding
Jul 18, 2016 | Consumer Advocacy News
By Andrew Steinberg
A Texas woman joined the multidistrict litigation against Xarelto manufacturers, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) and Bayer AG, after suffering severe complications from taking the popular blood thinner. The woman alleges the drug’s manufacturers failed to warn the public of the serious bleeding risks associated with Xarelto.
The woman began taking Xarelto in April 2014 to manage her risk of blood clots. However, in only a few months time, she experienced a life-threatening bleeding event requiring hospitalization.
Although all blood thinners come with the risk of excessive bleeding, Xarelto is particularly dangerous because it has no antidote. In the event of uncontrollable bleeding, there is no consistent way to reverse Xarelto’s effects. This has led many to believe the FDA Should Never Have Approved Xarelto.
When Xarelto was granted approval by the FDA in 2011, it wasn’t without controversy. Medical reviewers originally voted against Xarelto’s approval, but an advisory committee later granted it.
Adding to the controversy was the recall of the Blood Monitoring Device used in the pivotal 2014 Xarelto clinical trial. The device was recalled for providing erroneous readings. Plaintiffs allege the erroneous readings compromised Xarelto’s clinical trial data. To make matters worse, a recent study found Xarelto patients were twice as likely to experience uncontrollable bleeding events than patients taking Warfarin, another type of blood thinner. For plaintiffs in the Xarelto litigation, the risks of the drug far outweigh the benefits.Xarelto Lawsuits
In December 2014, thousands of Xarelto lawsuits were consolidated in the Eastern District of Louisiana with District Judge Eldon Fallen overseeing the proceedings. Since then, the number of lawsuits has grown to more than 5,300. Four bellwether trial dates have been scheduled for 2017 and both sides are working on selecting cases.
http://baddrug.news/news/texas-woman-files-xarelto-lawsuit-dangerous-bleeding/
-
Studies could authenticate plaintiff claims in Xarelto Lawsuit
Jul 19, 2016 | Zhong Zhilihe
According to a new report from Product Layers, two new types of research have come forward which could prove to be crucial in the upcoming litigation against Xarelto. Currently facing the heat from more than 2800 lawsuits in a multidistrict litigation, Bayer and Johnson & Johnson – the manufacturers of Xarelto (rivaroxaban), would be cursing their luck after a single glance at the new pieces of evidence.
Contrary to all the other researches – which have either been presented by the plaintiffs or defendants in the court, this research has been carried out by an independent group of researchers. The research generates a well-defined connection between the use of the Novel Oral Anticoagulant (NOAC) and the diseases i.e. gastrointestinal bleeding and eye infection.
The United States Judicial Council has consolidated more than 2200-cases in a single lawsuit. In all these cases common allegations have been filed against Xarelto. The Lawsuit of MDL # 2592 will be presented before Judge Eldon Fallon in the Eastern District of Louisiana.
In addition to this lawsuit, yet another one has been filed in the Philadelphia Court of Common Pleas. In this lawsuit, more than 550 cases have been consolidated to create a mass tort program.
What is Xarelto?
Not a traditional blood thinning medicine by any means, Xarelto revolutionized the drug market after its introduction a few years back. Before its introduction, the likes of warfarin were dominating the drug market. However, once Xarelto was introduced, it became the Number 1 blood thinning drug in the United States.
The major reason for the success of Xarelto was its general dosage for all the patients. Unlike to those of its competitors, a general dose of Xarelto was prescribed by the doctors to all patients. However, in the case of warfarin, blood tests were necessary before dishing out the medicine to the patients.
Research # 1: Linking Xarelto to Vitreous Hemorrhages
The first research, which was carried out by a team of doctors was published in the JAMA Opthalmology’s issue of June 2015. This research took into account the patients who were taking Xarelto from some time. However, in contrast to the other researches, this research was carried out on patients who weren’t parties in the case. Therefore, when it comes to the impartiality of this research, it is safe to say that it would carry huge weight in front of the court.
The patients who were tested in this research aged from 70 – 80. All these patients had used traditional anticoagulants at some stage in their life. Moreover, they had switched to using Xarelto only in the last few years.
As stated by the research in a damning indictment of Xarelto, in “all the cases”, an acute vitreous hemorrhage was formed in the patient after taking Xarelto for some time. Moreover, the doctors voiced their opinion that their research – which would be presented in the court, should refrain the doctors from prescribing the medicine to their patients.
Research # 2: Linking Xarelto to Gastrointestinal Bleeding
In yet another research which was published in the 2015’s April Issue of the British Medical Journal, more damning information was produced linking Xarelto to stomach bleeding. This research will, therefore, present more convincing information to the court.
Under this research, more than 46,000 patients were being tested to carve out the results of taking one of the new blood thinners. As you might note from the scale of information, the result of this research would carry more weight in the court.
Two types of patients were researched in this case. In the first category, those patients were tested who are taking the traditional anticoagulants. In the 2nd one, patients who are on Xarelto were tested.
The researchers noted that in patients who were taking rivaroxaban in place of the traditional blood thinning anti-coagulants, the apparent risk of contracting stomach bleeding was two times greater than their counterparts.
In addition to the above-mentioned researches, one thing that would add to the headache of the the drug’s manufacturers is the ever increasing number of lawsuits. At this stage, they are facing lawsuits in the region of 2800. However, as per the plaintiffs, more and more people will join their forces once an undeniable evidence is presented to the court.
What could be the financial Implications?
In 2013 alone, Bayer and Johnson and Johnson had made more than $1.3billion from the profits of their drugs. Therefore, while the current fiscal numbers are not released by them, it seems that they would have to pay a handsome amount in case of a verdict in favor of the plaintiffs.
http://www.zhongzhilihe.com/studies-could-authenticate-plaintiff-claims-in-xarelto-lawsuit/
-
Anticoagulant Xarelto Lawsuit Cases Keep Drawing Attention
Jul 20, 2016 | News Inferno
By Mara Lepmanis
Lawsuits seeking damages from the makers of Xarelto, Bayer AG and Janssen Pharmaceuticals (a subdivision of Johnson & Johnson), have surpassed 3,000 in number with many plaintiffs alleging they suffered similar harm resulting from taking the drug, reports the Digital Journal.
The U.S. Judicial Panel on Multidistrict Litigation elected to merge 2,800 individual cases into a multidistrict litigation (MDL) with the purpose of expediting the process. The MDL has been consolidated in U.S. District Court for the Eastern District of Louisiana. A similar situation occurred in Pennsylvania, where 550 cases merged to form a mass tort program, coordinated by the Philadelphia Court of Common Pleas.
The reasoning behind these combinations lies in the similarity of allegations brought against the drug manufacturers. People claim that neither they nor their physicians were sufficiently apprised of the potential elevated risk for the occurrence of sudden dangerous bleeding events associated with taking Xarelto. They were therefore, placed in danger of serious harm without due knowledge, according to the Digital Journal.
In 2011, the U.S. Food and Drug Administration (FDA) granted approval to Xarelto for the treatment of individuals suffering from pulmonary embolism or deep vein thromboses and for those recovering from hip or knee replacement surgery. Shortly thereafter, its approval was expanded to treat those with atrial fibrillation, a heart condition that increases the potential for stroke.
http://www.newsinferno.com/anticoagulant-xarelto-lawsuit-cases-keep-drawing-attention/
-
Xarelto Lawsuit: Manufacturers Were Warned About Misleading Ads
Jul 19, 2016 | Top Class Actions
By Tamara Burns
A lawsuit has been filed against Janssen Pharmaceuticals and Bayer AG by a group of 10 people whose family members had allegedly died from Xarelto use.
Filed in St. Clair County Circuit Court, the Xarelto lawsuit alleges that family members suffered blood thinner side effects that ultimately caused excessive internal bleeding that turned fatal.
The Xarelto lawsuit states that U.S. Food and Drug Administration (FDA) had issued a warning to the manufacturers informing them that the claims included in their marketing campaign for Xarelto were misleading.
Despite this written communication from the FDA, the plaintiffs allege that the manufacturers continued in their advertisement of Xarelto without making any changes to their public outreach campaign.
Although both Bayer and Janssen were allegedly aware of the potentially dangerous Xarelto side effects, the plaintiffs in the Xarelto lawsuit allege that the manufacturers continued to market the drug as safe and effective in the treatment of atrial fibrillation and for those who have undergone hip and knee replacement surgeries.
Xarelto is used to prevent blood clots in patients with atrial fibrillation, a condition where an abnormal heart rhythm improperly pumps blood. Patients with atrial fibrillation are more likely to have blood clots, which can be deadly.
In major surgeries such as hip and knee replacement surgeries, blood thinners are used proactively to avoid any potential blood clots related to surgery.
The plaintiffs in the Xarelto lawsuit also claim that the manufacturers used celebrity spokespersons to falsely promote Xarelto and neglected to adequately warn the public of the potentially dangerous blood thinner side effects.
The families in the lawsuit allege nine counts against Janssen and Bayer including wrongful death and fraud. The families are seeking compensatory damages in the amount of $50,000 per each deceased family member.
This Xarelto lawsuit is one of many currently pending in the state and federal courts. Due to the large number of Xarelto lawsuits, more than 2,800 have been consolidated into a multidistrict litigation in federal court in Louisiana.
An additional 550 cases were grouped in a mass tort program in Pennsylvania.
Xarelto Side Effects
Xarelto (dabigatran) is a member of the newer class of drugs referred to as New Oral Anticoagulants and was released in 2011.
When Xarelto and other new drugs in this class were introduced, they were seen as a positive alternative to the staple anticoagulant, warfarin (Coumadin) that was used for six decades prior.
Xarelto and other new blood thinner medication did not require frequent monitoring nor did it require patients to adopt a specific diet while taking the medication, in contrast to warfarin.
However, like all anticoagulants, Xarelto carried blood thinner side effects surrounding the risk of excess bleeding. Since all anticoagulant drugs are designed to prevent clotting in the body, the result is a risk of increased bleeding.
For patients who were on warfarin, if there was a bleeding emergency, an antidote could be administered to quickly reverse the anticoagulant mechanism of the medication and restore the body’s natural clotting properties.
Fresh frozen plasma and intravenous vitamin K serve as a reversal agent for warfarin.
Xarelto, however, lacks any type of reversal agent or antidote to counteract excessive bleeding. At best, patients may be hospitalized in order to stabilize them as the body processes the remaining Xarelto out of the patient’s system.
Unfortunately, as was the case for the families in this Xarelto lawsuit, the excess bleeding can be fatal.
Patients and families who have suffered from excessive bleeding Xarelto side effects ranging from permanent organ damage to death have filed a Xarelto lawsuit to hold the manufacturers accountable for producing what they believe is a dangerous drug.
If you or a loved one suffered from severe Xarelto side effects, a lawyer can review your case at no charge and help you decide if filing a Xarelto lawsuit is right for you.
https://topclassactions.com/lawsuit-settlements/lawsuit-news/339409-xarelto-lawsuit-manufacturers-warned-misleading-ads/
-
Hire a Xarelto Lawyer for Its Dangerous Side Effects
Jul 21, 2016 | Healthable
By Editorial
All the more usually known as Xarelto is essentially a FXa inhibitor that aides in the shirking of profound vein thrombosis that may bring about pneumonic embolism in individuals who are experiencing a hip or knee substitution surgery. Remember that your specialists will just recommend you to it if they judge that it will advantage you in one way or the other. He will likewise remember that there are a few symptoms that this medication causes, so theadvantage of this medication must be more noteworthy than the danger of reactions in your specific case. A great deal of times it does not have any serious symptoms.
In any case, this medication can likewise wind up bringing about genuine dying, if it seriously affects a patient’s blood thickening proteins. Probably the most genuine reactions that a patient on this may have incorporate unordinary torment, feeling of inconvenience, swelling of body parts, wounds showing up for no evident reason, amplified seeping from gums or cuts, consistent or intermittent nosebleeds and many other reactions. It is essential to remember that the individuals who experience the ill effects of these undesirable reactions can get pay for their physical and enthusiastic misfortunes. yet they ought to likewise know about the way that keeping in mind the end goal to get remuneration for the symptoms, the patient probably been admitted to a healing facility so that there is a proof as therapeutic reports that can be exhibited in the court as confirmation.
The patient should likewise have been taking the solution routinely when the reactions were watched. If the sufferer was off the medicine, it must be for a brief span period i.e. not over a week. This is essential since the half life of this medication is entirely short, so if the patient has been off of it for a more drawn out day and age then it turns out to be terribly difficult to exhibit that a specific well being condition was in actuality a reaction of Xarelto.
If you have experienced genuine well being entanglements, as an aftereffect of taking this, you ought to realize that its Xarelto Lawsuit can been recorded against Bayer AG and Janssen; the creators of the medication, with the goal that you can be adjusted for your misfortunes. The most ideal approach is to contract a legal advisor from a law office that has sound information with respect to these cases. Actually the Xarelto lawyers are having more experience and they are giving the right compensation to their clients. At the time of treatment it is very difficult to face the medical expenses so our lawyers understand the situation of them.
The Meldofsky Firm manages imperfect gadget and perilous medication damage cases coming about because of this. They go an additional mile to furnish their customers with the assets and administrations they need, to look for remuneration taking after a damage or wrongful passing. They work with customers from everywhere throughout the United States who have experienced wounds.
http://www.healthable.org/hire-a-xarelto-lawyer-for-its-dangerous-side-effects/
-
Know something about the Health Issues from Xarelto Lawsuit
| Medical Island
By Julius Rogers
In the legal and medication world, there is much going on today. All this is due to a drug that has caused more harm than it claims it can cure. There is a large volume of lawsuits filed by patients who used Xarelto. It is a medication used for blood thinning which was approved by the Food and Drug Association (FDA) in the year 2011. However, the drug turned out to be a disaster with exhilarating side effects to most people who consumed the drug. Regardless the fact that most drugs have side effects, Xarelto is exceptional after information emerged that it was approved carelessly without knowing its harm. The drug was made by Bayer and widely marketed and distributed by Janssen Pharmaceuticals in Japan a section of Johnson and Johnson.
What is Xarelto?
Xarelto is a new anticoagulant that claims to help in preventing extremely dangerous blood clots with higher risks of restricting flow to essential body organs. Most people who suffer from the condition by the name blood thinning need a customized dosage prescription from a qualified physician. However, Xarelto works as a single even done and is said to treat several similar conditions. In most cases, it is prescribed to patients who have hip or knee replacement surgery to minimize the risk of blood clot.
Xarelto Side Effects
When this drug was approved, none of its severe side effects was known. It causes severe and uncontrolled bleeding. In instances where bleeding occurs adjacent to a major body organ, its flow is ceased or interrupted. When that organ is either the lungs, kidneys or the brain can lead to a severe health complication.
Xarelto, in that case, is a good blood thinner and stops blood from clotting. As a result, this can lead to the formation of blood pools in the body until it completely gets flushed from the body system. All available coagulants have higher risks of causing internal bleeding. However, this isn’t a big deal since they are designed to assist in blood thinning of which they perfectly do. In most cases, most of these coagulants come with antidotes something that lacked from Xarelto, and you can`t flush off the body system. It is due to this that once bleeding starts from a patient who is taking the medicine, they are hospitalized and in the most cases, the majority has died. The drug can cause a brain hemorrhage, minimal platelet level, severe liver functionality, and abdominal bleeding.
It is due to these reasons that most Xarelto patients have gone ahead and filed lawsuits arguing that precise information wasn’t provided regarding the drug`s side effects and also due to the lack of an effective antidote. If you are a Xarelto Patient or one of your relatives has been affected by these deadly side effects of this drug, get in touch with the Xarelto Lawsuit for the most qualified and highly experienced Xarelto claim lawyers. We will evaluate your legal options for free, and you never know, you might be eligible for a significant amount of settlement.
Why us?
Xarelto lawyers have a vast experience in dealing with Xarelto victims. Over the years, we have represented Xarelto victims and won their cases offering them a fair compensation for their suffering. Our attorneys care about knowing our client’s background since we understand the pain and agony these clients have experienced. We fully understand how painful experience is of losing a loved one. Also, we know that winning a lawsuit for you will go a great way of compensating those financial losses incurred due to medical expenses.
http://www.medicalisland.net/health-guide/know-something-about-the-health-issues-from-xarelto-lawsuit
-
New Jersey Couple Alleges Xarelto Caused Stroke
Jul 21, 2016 | Top Class Actions
By Joanna Szabo
A New Jersey couple recently filed a Xarelto lawsuit against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, alleging that Xarelto caused stroke.
According to the lawsuit, Xarelto caused strokesymptoms in Barbara S. Barbara used Xarelto for a very short period of time, and took it at the direction of her doctor between July 13, 2014 and July 21, 2014.
However, she allegedly soon suffered from a Xarelto caused stroke on July 21, 2014.
The lawsuit alleges that the Xarelto caused stroke also resulted in physical pain, hospitalization and medical treatment, lost wages, and other damages.
The Xarelto lawsuit was filed on multiple counts, including strict liability, manufacturing defect, design defect, failure to warn, negligence, breach of express and implied warranties, negligent misrepresentation, and fraud. Barbara’s husband also filed for loss of consortium.
Xarelto Background
Xarelto (generic name rivaroxaban) is one of the most popular blood thinner drugs available on the market. Xarelto is most often prescribed for the treatment of blood clots. In most cases, blood clots are dangerous, and for some can even be fatal.
Despite its popularity, there are a rapidly rising number of Xarelto lawsuits being filed against Janssen Pharmaceuticals. These lawsuits allege that Janssen knew about but failed to warn consumers and the medical community of the potentially serious side effects of Xarelto.
In certain extreme situations, such as a serious accident or emergency surgery, the body purposely forms blood clots in order to stave the bleeding, preventing an injury from bleeding out. However, if the injured person is taking a blood thinner, they may be unable to form these life-saving clots.
Xarelto Lawsuits
Plaintiffs involved in recent Xarelto lawsuits include a variety of Xarelto bleeding side effects.
Gastrointestinal bleeding (GI bleeding)
Rectal bleeding
Uterine bleeding
Hemorrhaging
Brain hemorrhaging
Hermarthrosis (bleeding into joint spaces)
Bloody stool
Minor bleeding (nosebleeds, heavy menstrual flow)
In many cases, these Xarelto side effects are treatable, and patients can fully recover. However, for some, serious Xarelo side effects can lead to permanent injury or even death.
Unfortunately, some plaintiffs involved in these lawsuits against Janssen are family members of loved ones who have died after taking Xarelto and suffering from Xarelto caused stroke or another serious complication.
Xarelto lawsuits allege that Janssen Pharmaceuticals, despite knowledge of serious problems linked with Xarelto, failed to adequately warn both the public and the medical community about the problems connected with their drug.
In failing to warn about these potential complications, Xarelto lawsuits allege that Janssen placed Xarelto users at risk of serious or even fatal consequences.
Xarelto Lawsuits
Xarleto lawsuits allege that despite knowledge to the contrary, Janssen Pharmaceuticals continued to market Xarelto as completely safe and effective and diminished and downplayed its side effects, portraying the drug as if its benefits outweighed its risks.
Filing a Xarelto lawsuit cannot take away the pain and suffering of someone who has experienced severe Xarelto side effects like Xarelto caused stroke, and cannot bring a loved one back to life.
However, a Xarelto lawsuit can at least help to compensate for the financial expenses often incurred by medical bills and lost wages.
If you or someone you love has experienced severe Xarelto side effects, you may be able to file a Xarelto side effects lawsuit.
The Xarelto Lawsuit is filed within In Re: Xarelto Products Liability Litigation, MDL No. 2592, in the U.S. District Court for the District of New Jersey.
https://topclassactions.com/lawsuit-settlements/prescription/339840-new-jersey-couple-alleges-xarelto-caused-stroke/
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
Plaintiff Attorney Press Releases
Plaintiff Attorney Blog Posts
Full Text of Stories Below
Add recipients
Suggested